Xiaoping Chen
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in ⓘ
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 15
- Diabetes Treatment and Management 6
- Hormonal Regulation and Hypertension 6
- Diabetes Management and Education 3
- Diabetes Management and Research 2
- Co-authors
- Sen He (11 shared papers)Yan Chen (1 shared paper)Yong Peng (4 shared papers)Kaijun Cui (5 shared papers)Di Shi (4 shared papers)Si Wang (5 shared papers)Longxin Li (1 shared paper)Liyan Wan (1 shared paper)
- Journals
- Hypertension Research (2 papers)World Journal of Diabetes (2 papers)Diabetes Research and Clinical Practice (2 papers)The American Journal of the Medical Sciences (2 papers)PLoS Medicine (1 paper)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Xiaoping Chen
36 papers receiving 440 citations
Peers
Comparison fields: 5 of 86
- Endocrinology, Diabetes and Metabolism 178
- Complementary and alternative medicine 45
- Pharmacology 88
- Pharmacology 39
- Biochemistry 22
Countries citing papers authored by Xiaoping Chen
This map shows the geographic impact of Xiaoping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Chen more than expected).
Fields of papers citing papers by Xiaoping Chen
This network shows the impact of papers produced by Xiaoping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Chen. The network helps show where Xiaoping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 104 | |
| 2 | 2011 | 75 | |
| 3 | 2014 | 42 | |
| 4 | 2018 | 40 | |
| 5 | 2012 | 28 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 11 | |
| 8 | 2010 | 11 | |
| 9 | 2017 | 11 | |
| 10 | 2011 | 10 | |
| 11 | 2020 | 10 | |
| 12 | 2022 | 10 | |
| 13 | 2013 | 9 | |
| 14 | 2019 | 9 | |
| 15 | Hypercholesterolemia Up-Regulates the Expression of Intermedin and Its Receptor Components in the Aorta of Rats via Inducing the Oxidative Stress. | 2016 | 9 |
| 16 | 2011 | 7 | |
| 17 | 2013 | 6 | |
| 18 | 2013 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2018 | 5 |
About Xiaoping Chen
Xiaoping Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Orthopedics and Sports Medicine, Clinical Biochemistry and Complementary and alternative medicine, having authored 37 papers that have together received 458 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Diabetes Treatment and Management (6 papers), Hormonal Regulation and Hypertension (6 papers), Metabolism, Diabetes, and Cancer (4 papers), Diabetes Management and Education (3 papers), Sports Performance and Training (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Diabetes Management and Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (178 citations), Complementary and alternative medicine (45 citations), Pharmacology (88 citations), Pharmacology (39 citations) and Biochemistry (22 citations). Xiaoping Chen has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Sen He, Yan Chen, Yong Peng, Kaijun Cui, Di Shi, Si Wang, Longxin Li, Liyan Wan, Kai Liu and Yong Wang. Their work appears in journals such as Hypertension Research, World Journal of Diabetes, Diabetes Research and Clinical Practice, The American Journal of the Medical Sciences and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.